Besides, significant overexpression of AURKA was revealed in human GC samples, the inhibition of which using an investigational small-molecule specific inhibitor, alisertib, could markedly decrease the in vitro cell survival and in vivo xenograft tumor growth by diminishing the HDM2 protein level and inducing P53 transcriptional activity [20]. The gene discussed is TP53; the disease is neoplasm.